Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Trauma can lead to nightmares, hypervigilance, and fragmented sleep
RP1 in advanced melanoma: a panel vote reverses the mood before 2 August Replimunes oncolytic immunotherapy RP1 (vusolimogene oderparepvec), given with nivolumab, has a goal date of 2 August 2026 for advanced melanoma that has progressed on anti-PD-1 therapy
Gut Bacteria and Neurotransmitters
F., Chen, N., Simmler, C., Lankin, D
The concern: the same pathways that promote healing can also be hijacked by cancer cells
US$ 20.88
US$ 23.73
US$ 28.51
US$ 23.09
